Free Trial

Calliditas Therapeutics AB (publ) (CALT) Earnings Date, Estimates & Call Transcripts

Calliditas Therapeutics AB (publ) logo
$40.00 0.00 (0.00%)
(As of 11/15/2024 ET)

Calliditas Therapeutics AB (publ) Latest Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 13Confirmed
Actual EPS
(Aug. 13)
-$0.16 Beat By $0.09
Consensus EPS
(Aug. 13)
-$0.25

Calliditas Therapeutics AB (publ) released Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.16, which beat analysts' consensus estimates of -$0.25 by $0.09. Quarterly revenue was reported to be $52.36 million, above the consensus estimate of $42.89 million. With a trailing EPS of -$1.85, Calliditas Therapeutics AB (publ)'s earnings are expected to grow next year, from ($0.99) to $4.61 per share.

Get Calliditas Therapeutics AB (publ) Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Calliditas Therapeutics AB (publ) and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CALT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CALT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Calliditas Therapeutics AB (publ) Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.68$0.68$0.68
Q2 20241$0.80$0.80$0.80
Q3 20241$0.90$0.90$0.90
Q4 20241$0.83$0.83$0.83
FY 20244$3.21$3.21$3.21

Calliditas Therapeutics AB (publ) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/13/2024Q2 2024-$0.25-$0.16+$0.09-$0.16$42.89M$52.36M    
5/23/2024Q1 2024-$0.14-$0.88 -$0.74-$0.88$35.78M$28.43M    
2/21/2024Q4 2023-$0.09-$0.07+$0.02-$0.06$36.24M$42.45M    
11/7/2023Q3 2023-$0.22-$0.58 -$0.36-$0.58$28.09M$27.25M
8/17/2023Q2 2023-$0.25-$0.33 -$0.08-$0.33$28.34M$25.60M
5/16/2023Q1 2023-$0.57-$0.67 -$0.10-$0.67$19.05M$18.32M
2/23/2023Q4 2022-$0.47-$0.01+$0.46-$0.01$18.93M$40.04M

Calliditas Therapeutics AB (publ) Earnings - Frequently Asked Questions

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on CALT's earnings history.

In the previous quarter, Calliditas Therapeutics AB (publ) (NASDAQ:CALT) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.09. Learn more on analysts' earnings estimate vs. CALT's actual earnings.

The conference call for Calliditas Therapeutics AB (publ)'s latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Calliditas Therapeutics AB (publ)'s latest earnings report can be read online.
Read Transcript

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) has a recorded annual revenue of $1.60 billion.

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) has a recorded net income of -$43.96 million. CALT has generated -$1.85 earnings per share over the last four quarters.

Calliditas Therapeutics AB (publ)'s earnings are expected to grow from ($0.99) per share to $4.61 per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CALT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners